中国英派药业计划通过香港IPO筹资至多1.17亿美元--发行条款清单

路透中文
May 05
中国英派药业计划通过香港IPO筹资至多1.17亿美元--发行条款清单

路透新加坡5月5日 - 据路透周二看到的一份发行条款清单,中国抗癌药物开发商英派药业(Impact Therapeutics)7630.HK计划通过在香港首次公开发行$(IPO)$筹资至多1.17亿美元。

  • 英派药业计划以每股19.75至21.75港元(2.52至2.78美元)的价格发行4198万股股份。

  • 若承销商行使超额配售权,此次募资规模可能增至1.34亿美元。

  • 包括腾讯0700.HK在内的六家基石投资者将认购约3570万美元的股份。

  • 英派药业预计将于5月11日确定IPO价格,并于5月13日上市。(完)

(编审 汪红英)

((Hongying.wang@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10